| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 0 | 1.683 | 8.761 | 12.247 | 8.871 | 9.413 | 13.202 | 20.569 | 19.847 |
| Total Income - EUR | - | 0 | 2.449 | 8.761 | 12.247 | 9.763 | 9.414 | 13.202 | 20.570 | 19.854 |
| Total Expenses - EUR | - | 13 | 9.356 | 13.507 | 14.917 | 10.743 | 9.377 | 11.325 | 17.816 | 19.977 |
| Gross Profit/Loss - EUR | - | -13 | -6.907 | -4.745 | -2.670 | -980 | 37 | 1.878 | 2.754 | -123 |
| Net Profit/Loss - EUR | - | -13 | -6.932 | -4.833 | -2.792 | -1.040 | 37 | 1.807 | 2.548 | -719 |
| Employees | - | 0 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
Check the financial reports for the company - Nicoole&Clinic S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 5.839 | 3.873 | 1.975 | 149 | 0 | 0 | 6 | 0 |
| Current Assets | - | 7.158 | 705 | 517 | 993 | 1.263 | 494 | 883 | 1.250 | 724 |
| Inventories | - | 0 | 479 | 354 | 363 | 404 | 375 | 128 | 119 | 247 |
| Receivables | - | 3.470 | 0 | 0 | 0 | 2 | 2 | 0 | 627 | 0 |
| Cash | - | 3.688 | 226 | 163 | 630 | 857 | 117 | 755 | 504 | 477 |
| Shareholders Funds | - | 32 | -6.900 | -11.607 | -14.174 | -14.946 | -14.577 | -12.816 | -10.229 | -10.891 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 7.126 | 13.444 | 15.996 | 17.142 | 16.358 | 15.072 | 13.699 | 11.485 | 11.615 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Nicoole&Clinic S.r.l.